We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACT.L Regulatory News (ACT)

  • There is currently no data for ACT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Intention to Appoint Administrators & Suspension

7 Nov 2023 07:00

RNS Number : 5593S
Actual Experience PLC
07 November 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018) ("UK MAR")). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF THE PLACING WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF INSIDE INFORMATION (AS DEFINED IN UK MAR), AS PERMITTED BY UK MAR. THIS INSIDE INFORMATION IS SET OUT IN THIS ANNOUNCEMENT. THEREFORE, THOSE PERSONS THAT RECEIVED INSIDE INFORMATION IN A MARKET SOUNDING ARE NO LONGER IN POSSESSION OF SUCH INSIDE INFORMATION RELATING TO THE COMPANY AND ITS SECURITIES.

 

FOR IMMEDIATE RELEASE

 

7 November 2023

 

Actual Experience plc

Company Update, Intention to Appoint Administrators and Suspension of Trading in Shares

Actual Experience plc (AIM: ACT), the analytics-as-a-service company (the "Company" and, together with its subsidiary undertakings, the "Group"), provides the following update regarding its recent trading performance, financial position, and efforts to raise further funding.

Introduction

The Company disclosed in its unaudited consolidated interim results for the six months ended 31 March 2023 (the "Interim Results", released on 12 June 2023) that, based on its latest "base case" assessment, and in the absence of cost reductions or significant commercial progress, the Company was forecast to run out of cash by December 2023. As part of the Interim Results, the Company's board of directors (the "Board") also prepared a severe, but plausible, downside scenario based on significantly more pessimistic sales forecasts, with corresponding reductions in controllable costs. In this scenario, the Company was forecast to run out of cash by November 2023. 

Current Trading and Financial Position

During the financial year ended 30 September 2022, the Company reduced ongoing expenses from £680,000 per month to £460,000 and expenses have been maintained at this level during the financial year ended 30 September 2023 ("FY2023"). During FY2023 and subsequently, the Board has been constantly reviewing the Company's cost profile and organisational structure, however, the Board also formed the view that the Company had reduced headcount and its operating cost base to the lowest viable level while still retaining the ability to deliver commercial objectives regarding order acquisition and customer support, as well as developing additional required product features.

Although the Company made commercial progress during FY2023, securing new revenue contracts and significant sales has taken longer than expected and, as a result, trading has largely tracked the severe, but plausible, downside scenario announced in the Interim Results. This, along with additional costs exploring strategic options as outlined below, has resulted in a depletion of the Company's cash reserves and without new funding, the Company would have inadequate funds to continue trading after late November 2023.

Strategic Options

The Company also announced in the Interim Results that if it were unable to secure an appropriate combination of new revenue contracts, cost reductions, and/or further funding, then the Company may not have sufficient resources to meet its liquidity requirements over the foreseeable future. As described above and at the current time, the Company has been unable to secure significant new revenue contracts or cost reduction and so the Board has been exploring an equity fundraise to increase the Company's cash reserves and has been in active discussions with existing and potential shareholders over the last few months.

On 14 August 2023, the Company submitted a letter to HMRC seeking advanced assurance under the Income Tax Act 2007 that it is eligible to issue shares to investors that would benefit from relief from taxation under the enterprise investment scheme ("EIS") regime, reflecting the Board's view that receiving advanced assurance from HMRC provided the greatest chance for a successful equity fundraise. While exploring an equity fundraise, the Company has been in discussions with various venture capital trust and EIS funds along with other potential investors. Despite the Company submitting information and replying promptly to queries, HMRC have not, as at the date of this announcement, provided a formal response regarding the Company's application within HMRC's published timescales for responding to applications for advanced assurance.

It is the Board's view that it is now highly uncertain whether any formal approval regarding its application could be expected from HMRC within the required timescales, having regard to the Company's rapidly depleting cash reserves.

Alongside progressing a possible equity fundraise, the Company has explored other strategic options with the assistance of FRP Advisory Trading Limited ("FRP Advisory"), including an accelerated M&A process to seek an acquirer of the Group's business and assets, and contingency planning. In relation to accelerated M&A, FRP Advisory contacted a number of potential acquirers on the Company's behalf, however received no firm indications of interest in response. The Board therefore terminated this process due to the lack of interest and the significant ongoing costs involved.

Having considered the Company's rapidly depleting cash position and the lack of progress regarding an equity fundraise and the other strategic options explored, it is the Board's view that it is unlikely to be able to secure the funding that it requires or complete an alternative transaction in a timely manner to secure the Company's future and so is now taking action to protect value for the Company's creditors and other stakeholders.

The Board has therefore regrettably resolved to file a notice to appoint administrators to the Company with such appointment expected to take effect later today.

Resignation of nominated adviser and joint brokers

As a result of the Company's intention to appoint administrators, Singer Capital Markets Advisory LLP and Turner Pope Investments (TPI) Ltd have informed the Company of their resignations as nominated adviser and joint broker and joint broker to Actual Experience plc respectively, effective immediately on the release of this announcement. Pursuant to AIM Rule 1, if a replacement nominated adviser is not appointed within one month of today's date, the admission of the Ordinary Shares to trading on AIM will be cancelled. The Company has no current intention of appointing a replacement nominated adviser.

In light of the above, the Board announces that it has requested a suspension of trading in the Company's ordinary shares on AIM with effect from 07.30 a.m. today.

Further announcements will be made in due course.

Enquiries:

 

Actual Experience plc

Iain McCready, CEO

Steve Bennetts, CFO

Tel: +44 (0)207 129 1474

Singer Capital Markets Advisory LLP

Shaun Dobson

James Fischer

Tel: +44 (0)207 496 3000

Turner Pope Investments (TPI) Ltd

James Pope

Andy Thacker

Tel: + 44 (0)203 657 0050

Flagstaff Strategic and Investor Communications

Tim Thompson

Mark Edwards

Andrea Seymour

Anna Probert

Tel: +44 (0)207 129 1474

actual@flagstaffcomms.com

 

 

The person responsible for arranging release of this announcement on behalf of the Company is Steve Bennetts, Chief Financial Officer. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKQLFBXFLZFBB
Date   Source Headline
8th Dec 20237:00 amRNSCancellation - Actual Experience plc
7th Nov 20235:30 pmRNSActual Experience
7th Nov 202311:26 amRNSAppointment of Administrators
7th Nov 20237:30 amRNSSuspension - Actual Experience plc
7th Nov 20237:00 amRNSIntention to Appoint Administrators & Suspension
3rd Oct 202312:15 pmRNSShare Scheme, Directors Dealings, Voting Rights
7th Sep 20239:35 amRNSShare Scheme, Directors Dealings, Voting Rights
3rd Aug 202312:03 pmRNSShare Scheme Directors Dealings Voting Rights
28th Jul 20232:00 pmRNSGrant of Options
26th Jul 20237:00 amRNSLogicalis to seek first customer for DWMP product
25th Jul 20237:00 amRNSSecond enterprise sale of new DWMP product
4th Jul 20234:26 pmRNSShare Scheme Directors Dealings Voting Rights
12th Jun 20237:00 amRNSInterim Results for six months ended 31 March 2023
7th Jun 202310:00 amRNSShare Scheme Directors Dealings Voting Rights
1st Jun 20237:00 amRNSAppointment of Chief Executive Officer
26th May 20237:00 amRNSAppointment of Chief Executive Officer
25th May 20237:00 amRNSDEFRA Contract Extension
3rd May 20237:00 amRNSShare Scheme Directors Dealings Voting Rights
27th Apr 20232:25 pmRNSDirectors / PDMR Dealings
4th Apr 20235:43 pmRNSEmployee Shares Directors Dealings Voting Rights
28th Mar 20232:54 pmRNSResult of AGM
21st Mar 20234:40 pmRNSSecond Price Monitoring Extn
21st Mar 20234:35 pmRNSPrice Monitoring Extension
21st Mar 20237:00 amRNSSignificant UK Central Government Contract
3rd Mar 202311:50 amRNSEmployee Share Scheme, Directors Dealings and TVR
28th Feb 20237:00 amRNSDirectorate Changes
3rd Feb 20235:56 pmRNSEmployee Share Scheme, Directors Dealings and TVR
1st Feb 202312:05 pmRNSHolding(s) in Company
27th Jan 20237:00 amRNSPreliminary Results
4th Jan 202311:23 amRNSEmployee Share Scheme, Directors Dealings and TVR
15th Dec 20227:00 amRNSTrading Statement
5th Dec 20225:00 pmRNSTotal Voting Rights
5th Dec 20227:00 amRNSGrant of Options
4th Nov 20222:22 pmRNSDirector/PDMR Shareholding
14th Oct 20229:42 amRNSHolding(s) in Company
13th Oct 20227:00 amRNSHolding(s) in Company
13th Oct 20227:00 amRNSHolding(s) in Company
13th Oct 20227:00 amRNSHolding(s) in Company
10th Oct 202212:00 pmRNSEmployee Share Scheme, Directors Dealings and TVR
10th Oct 20228:00 amRNSDirectorate Change
7th Oct 202211:04 amRNSResult of General Meeting and Admission
6th Oct 20225:09 pmRNSGrant of Options
23rd Sep 20224:17 pmRNSExercise of Broker Option
22nd Sep 20223:23 pmRNSHolding(s) in Company
21st Sep 20226:07 pmRNSResult of Placing and Subscription
21st Sep 202212:00 pmRNSProposed Placing, Subscription and Broker Option
12th Aug 202211:33 amRNSTR1: Notification of major holdings
4th Aug 20223:54 pmRNSCorrection: Employee Share Scheme, Dealings, TVR
2nd Aug 20227:00 amRNSEmployee Share Scheme, Directors Dealings and TVR
14th Jul 20222:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.